BIOTRONIK

BIOTRONIK ANNOUNCED FIRST IMPLANT OF NEW IMPLANTABLE CARDIAC MONITOR WITH ARTIFICIAL INTELLIGENCE, TARGETING EFFICIENCY IN MONITORING FOR CARDIAC ARRHYTHMIAS

by

Montefiore Medical Center in New York performed the first global implantation of the new BIOMONITOR IV ICM LAKE OSWEGO, Ore., June 12, 2023 /PRNewswire/ — BIOTRONIK, a leader in implantable medical device technology, today announced the first global implantation of its BIOMONITOR IV implantable cardiac monitor (ICM). The procedure was conducted by Luigi Di Biase, … Read more

LATE-BREAKING TRIAL PRESENTED AT HRS SHOWS MEASURABLE DIFFERENCE IN OUTCOMES BETWEEN PATIENTS BY SEX

by

BIOTRONIK continues to champion diversity in clinical trial enrollment with ongoing BIO-LIBRA Study LAKE OSWEGO, Ore., June 9, 2023 /PRNewswire/ — Data presented at Heart Rhythm Society’s 2023 Conference show a measurable difference in outcomes between male and female patients when looking at one-year ventricular tachyarrhythmia or death rates in patients with non-ischemic cardiomyopathy (NICM) … Read more